The total return over the past 12 months is -76.03% vs. +16.94% for the S&P 500. So far it's up -47.94% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (76.03%) | (43.88%) | (45.73%) | N/A | N/A | N/A |
| Total Return CAGR | (76.03%) | (43.88%) | (45.73%) | N/A | N/A | N/A |
| Revenue CAGR | (73.64%) | +308.87% | +2.41% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Humacyte, Inc. (HUMA)
| Year | Start price | End price | HUMA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.96 | $0.50 | (47.94%) | +14.51% | (62.45%) |
| 2025 | $5.05 | $0.96 | (80.98%) | +17.72% | (98.70%) |
| 2024 | $2.84 | $5.05 | +77.82% | +24.89% | +52.93% |
| 2023 | $2.11 | $2.84 | +34.60% | +26.19% | +8.41% |
| 2022 | $7.25 | $2.11 | (70.90%) | (18.17%) | (52.73%) |
| 2021 | $10.17 | $7.25 | (28.71%) | +28.74% | (57.45%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
